PUBLICATIONS · 28362562
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2017 May 20
- First author
- Casali PG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Transl Gastroenterol Hepatol. 2017 Nov 20;2:93. doi: 10.21037/tgh.2017.11.07.
- note
- Source null
- related pmid
- 29264431
- relationship
- Comment in
- citation
- Transl Gastroenterol Hepatol. 2017 Nov 20;2:94. doi: 10.21037/tgh.2017.11.08.
- note
- Source null
- related pmid
- 29264432
- relationship
- Comment in
Authors and identifiers
- name
- Casali PG
- type
- Author
- name
- Zalcberg J
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Reichardt P
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Lindner LH
- type
- Author
- name
- Judson IR
- type
- Author
- name
- Schöffski P
- type
- Author
- name
- Leyvraz S
- type
- Author
- name
- Italiano A
- type
- Author
- name
- Grünwald V
- type
- Author
- name
- Pousa AL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Casali PG
- type
- Author
- name
- Zalcberg J
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Reichardt P
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Lindner LH
- type
- Author
- name
- Judson IR
- type
- Author
- name
- Schöffski P
- type
- Author
- name
- Leyvraz S
- type
- Author
- name
- Italiano A
- type
- Author
- name
- Grünwald V
- type
- Author
- name
- Pousa AL
- type
- Author
- bibliography ids
- nci-bib-f4eac5c299d2b26400661ecf
- book metadata
- content sha256
- 3c87da27a1e3c9edea08ae673f459ff9cbb9b4acd90ad21f4635363695d6dfa2
- document type
- citation
- dois
- 10.1200/JCO.2016.71.0228
- electronic publication date
- display
- 2017 Mar 31
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28362562
- immutable id
- pubmed:28362562@3c87da27a1e3c9edea08ae673f459ff9cbb9b4acd90ad21f4635363695d6dfa2
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 15
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1713-1720
- volume
- 35
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Transl Gastroenterol Hepatol. 2017 Nov 20;2:93. doi: 10.21037/tgh.2017.11.07.
- note
- Source null
- related pmid
- 29264431
- relationship
- Comment in
- citation
- Transl Gastroenterol Hepatol. 2017 Nov 20;2:94. doi: 10.21037/tgh.2017.11.08.
- note
- Source null
- related pmid
- 29264432
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 28362562
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- b543614e486bcacd91540f1bcccd682e77512c5861c7edbfb467a1b16e0fe815
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 May 20
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
Preserved source evidence · Not medical advice
Triangle